Compare Novartis AG (NVS) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs VF Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while VF Corp trades at $16.88 (market cap $6.62B). The key difference: Novartis AG is far larger — about 43.8× VF Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | VFC | |
|---|---|---|
Market Cap | $290.25B | $6.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $21.55 |
52-Week Low | $113.50 | $11.66 |
Enterprise Value | $330.27B | $10.77B |
Dividend Yield | 3.17% | 2.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
